Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-10

FDA Approved: CROTAN — Supplemental Application (Marnel Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CROTAN (crotamiton) from Marnel Pharmaceuticals, Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CROTAN (CROTAMITON)

Snippet

SUPPL AP for CROTAN (CROTAMITON)